These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30798308)

  • 1. Shortening patient-reported outcome measures through optimal test assembly: application to the Social Appearance Anxiety Scale in the Scleroderma Patient-centered Intervention Network Cohort.
    Harel D; Mills SD; Kwakkenbos L; Carrier ME; Nielsen K; Portales A; Bartlett SJ; Malcarne VL; Thombs BD;
    BMJ Open; 2019 Feb; 9(2):e024010. PubMed ID: 30798308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Optimal Test Assembly Methods for Shortening Patient-Reported Outcome Measures: Development and Validation of the Cochin Hand Function Scale-6: A Scleroderma Patient-Centered Intervention Network Cohort Study.
    Levis AW; Harel D; Kwakkenbos L; Carrier ME; Mouthon L; Poiraudeau S; Bartlett SJ; Khanna D; Malcarne VL; Sauve M; van den Ende CH; Poole JL; Schouffoer AA; Welling J; Thombs BD;
    Arthritis Care Res (Hoboken); 2016 Nov; 68(11):1704-1713. PubMed ID: 27015290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Social Appearance Anxiety Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study.
    Mills SD; Kwakkenbos L; Carrier ME; Gholizadeh S; Fox RS; Jewett LR; Gottesman K; Roesch SC; Thombs BD; Malcarne VL;
    Arthritis Care Res (Hoboken); 2018 Oct; 70(10):1557-1562. PubMed ID: 29342510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study.
    Fox RS; Kwakkenbos L; Carrier ME; Mills SD; Gholizadeh S; Jewett LR; Roesch SC; Merz EL; Assassi S; Furst DE; Gottesman K; Mayes MD; Thombs BD; Malcarne VL;
    Arthritis Care Res (Hoboken); 2018 Nov; 70(11):1646-1652. PubMed ID: 29409146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing differential item functioning for the Social Appearance Anxiety Scale: a Scleroderma atient-centred Intervention Network (SPIN) Cohort Study.
    Sommer SJ; Harel D; Kwakkenbos L; Carrier ME; Gholizadeh S; Gottesman K; Leite C; Malcarne VL; Thombs BD;
    BMJ Open; 2020 Oct; 10(10):e037639. PubMed ID: 33046467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor structure and convergent validity of the Derriford Appearance Scale-24 using standard scoring versus treating 'not applicable' responses as missing data: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study.
    Merz EL; Kwakkenbos L; Carrier ME; Gholizadeh S; Mills SD; Fox RS; Jewett LR; Williamson H; Harcourt D; Assassi S; Furst DE; Gottesman K; Mayes MD; Moss TP; Thombs BD; Malcarne VL;
    BMJ Open; 2018 Mar; 8(3):e018641. PubMed ID: 29511009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Satisfaction with Appearance Scale and Its Short Form in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study.
    Mills SD; Fox RS; Merz EL; Clements PJ; Kafaja S; Malcarne VL; Furst DE; Khanna D
    J Rheumatol; 2015 Sep; 42(9):1624-30. PubMed ID: 26034157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of the brief-satisfaction with appearance scale for systemic sclerosis.
    Jewett LR; Hudson M; Haythornthwaite JA; Heinberg L; Wigley FM; Baron M; Thombs BD;
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1779-86. PubMed ID: 20665750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further support for the validity of the social appearance anxiety scale (SAAS) in a variety of German-speaking samples.
    Reichenberger J; Radix AK; Blechert J; Legenbauer T
    Eat Weight Disord; 2022 Apr; 27(3):929-943. PubMed ID: 34085203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social anxiety and fear of negative evaluation: construct validity of the BFNE-II.
    Carleton RN; Collimore KC; Asmundson GJ
    J Anxiety Disord; 2007; 21(1):131-41. PubMed ID: 16675196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Stirling Antenatal Anxiety Scale (SAAS): Turkish validity and reliability study.
    Çelebi EZ; Tozkır E; Çayır G; Murat M; Beji NK; Avcı N; Sinesi A
    Midwifery; 2024 Sep; 136():104073. PubMed ID: 38941783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Brief Fear of Negative Evaluation Scale (BFNE): translation and validation study of the Iranian version.
    Tavoli A; Melyani M; Bakhtiari M; Ghaedi GH; Montazeri A
    BMC Psychiatry; 2009 Jul; 9():42. PubMed ID: 19589161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Social Appearance Anxiety Scale: factor, convergent, and divergent validity.
    Levinson CA; Rodebaugh TL
    Assessment; 2011 Sep; 18(3):350-6. PubMed ID: 21467096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the COVID-19 Fears Questionnaires for Chronic Medical Conditions: A Scleroderma Patient-centered Intervention Network COVID-19 Cohort study.
    Wu Y; Kwakkenbos L; Henry RS; Tao L; Harb S; Bourgeault A; Carrier ME; Levis B; Sun Y; Bhandari PM; Carboni-Jiménez A; Gagarine M; He C; Krishnan A; Negeri ZF; Neupane D; Mouthon L; Bartlett SJ; Benedetti A; Thombs BD; ;
    J Psychosom Res; 2020 Dec; 139():110271. PubMed ID: 33096402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Body Concealment Scale for Scleroderma (BCSS): Replication in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort.
    Jewett LR; Kwakkenbos L; Carrier ME; Malcarne VL; Harcourt D; Rumsey N; Mayes MD; Assassi S; Körner A; Fox RS; Gholizadeh S; Mills SD; Fortune C; Portales A; Thombs BD;
    Body Image; 2017 Mar; 20():99-106. PubMed ID: 28068643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a new patient-reported outcome measure to assess activities and participation in people with systemic sclerosis: the Cochin 17-item Scleroderma Functional scale.
    Daste C; Abdoul H; Foissac F; Papelard A; Alami S; Kwakkenbos L; Carrier ME; Lefèvre-Colau MM; Thombs BD; Poiraudeau S; Rannou F; Mouthon L; Nguyen C
    Br J Dermatol; 2020 Oct; 183(4):710-718. PubMed ID: 32017013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Self-Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient-Centered Intervention Network Cohort Study.
    Riehm KE; Kwakkenbos L; Carrier ME; Bartlett SJ; Malcarne VL; Mouthon L; Nielson WR; Poiraudeau S; Nielsen K; Baron M; Frech T; Hudson M; Pope J; Sauve M; Suarez-Almazor ME; Wigley FM; Thombs BD;
    Arthritis Care Res (Hoboken); 2016 Aug; 68(8):1195-200. PubMed ID: 26619042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shortening self-report mental health symptom measures through optimal test assembly methods: Development and validation of the Patient Health Questionnaire-Depression-4.
    Ishihara M; Harel D; Levis B; Levis AW; Riehm KE; Saadat N; Azar M; Rice DB; Sanchez TA; Chiovitti MJ; Cuijpers P; Gilbody S; Ioannidis JPA; Kloda LA; McMillan D; Patten SB; Shrier I; Arroll B; Bombardier CH; Butterworth P; Carter G; Clover K; Conwell Y; Goodyear-Smith F; Greeno CG; Hambridge J; Harrison PA; Hudson M; Jetté N; Kiely KM; McGuire A; Pence BW; Rooney AG; Sidebottom A; Simning A; Turner A; White J; Whooley MA; Winkley K; Benedetti A; Thombs BD
    Depress Anxiety; 2019 Jan; 36(1):82-92. PubMed ID: 30238571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Greek Version of Social Appearance Anxiety Scale in Adolescents and Young Adults.
    Papapanou TK; Bacopoulou F; Michou M; Kanaka-Gantenbein C; Vlachakis D; Chrousos GP; Darviri C
    EMBnet J; 2023; 28():. PubMed ID: 37325083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for shortening patient-reported outcome measures.
    Harel D; Baron M
    Stat Methods Med Res; 2019; 28(10-11):2992-3011. PubMed ID: 30126324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.